ArticleJournal of the Society for Cardiovascular Angiography & Interventions2026
Safety and Feasibility of Same-Day Discharge After Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: A Single-Center Retrospective Study.
Article in Journal of the Society for Cardiovascular Angiography & Interventions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Balloon pulmonary angioplasty (BPA) is increasingly used for patients with inoperable or residual chronic thromboembolic pulmonary hypertension. Overnight observation is the current standard practice. We evaluated the safety and feasibility of same-day discharge (SDD) after BPA at a contemporary US referral center. Methods: We retrospectively analyzed consecutive chronic thromboembolic pulmonary hypertension patients undergoing BPA between 2018 and 2024. SDD was defined as discharge on the calendar day of BPA. The primary outcome was 30-day readmission or mortality; secondary outcomes included BPA-related complications. Predictors of SDD were assessed using mixed-effects logistic regression. Results: Seventy-seven patients underwent 262 BPA procedures; 89 (34%) were followed by SDD. Patients selected for SDD had higher baseline 6-minute walk distance (356 vs 270 m; Conclusions: Among patients meeting prespecified institutional eligibility criteria, SDD after BPA was feasible and not associated with increased 30-day adverse events. Structured SDD pathways guided by reproducible selection criteria may optimize resource utilization as BPA volumes continue to grow.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.